Emerging trends in candidemia: A higher incidence but a similar outcome

被引:59
作者
Fortun, J. [1 ]
Martin-Davila, P. [1 ]
Gomez-Garcia de la Pedrosa, E. [2 ]
Pintado, V. [1 ]
Cobo, J. [1 ]
Fresco, G. [1 ]
Meije, Y. [1 ]
Ros, L. [2 ]
Alvarez, M. E. [2 ]
Luengo, J. [1 ]
Agundez, M. [1 ]
Belso, A. [1 ]
Sanchez-Sousa, A. [2 ]
Loza, E. [2 ]
Moreno, S. [1 ]
机构
[1] Hosp Ramon & Cajal, Serv Enfermedades Infecciosas, Dept Infect Dis, E-28034 Madrid, Spain
[2] Hosp Ramon & Cajal, Dept Microbiol, E-28034 Madrid, Spain
关键词
Candidemia; Epidemiological changes; Risk; BLOOD-STREAM INFECTION; RISK-FACTORS; EPIDEMIOLOGY; MORTALITY; SURVEILLANCE; SPAIN; CANDIDIASIS; BREAKPOINTS; NATIONWIDE; HOSPITALS;
D O I
10.1016/j.jinf.2012.02.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The clinical presentation and outcome of candidemia has changed in recent years. We compared two 5-year periods (2000-2004 and 2005-2009) in a single institution. We recorded 419 candidemia episodes during the study period (124 in the first period and 295 in the second period). We observed a significant increase in the number of cases per 1000 admissions per year, from 0.57 in 2000 to 1.52 in 2009 (chi(2) LT <0.001). Candida albicans was the most frequently isolated species (42.2%), followed by Candida parapsilosis (34.4%) and Candida glabrata (12.9%). In the second period, episodes were associated with higher comorbidity and were more commonly nosocomial, with a more frequent catheter-related source and an increased rate of C. glabrata infection. No significant differences were observed in susceptibility by species during the study period. According to multivariate analysis, the independent factors associated with higher mortality were shock, age >50 years, elevated comorbidity score (Charlson index >6), and source of candidemia other than catheter. In contrast to the increase in comorbid conditions observed in recent years, mortality remained similar during both periods (similar to 37% during the first month). This finding could be attributed to a significant increase in catheter-related candidemia and better outcome, as well as to a potential improvement in the management of antifungal therapy in recent years. (C) 2012 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:64 / 70
页数:7
相关论文
共 21 条
[1]   Epidemiology and predictors of mortality in cases of Candida bloodstream infection:: Results from population-based surveillance, Barcelona, Spain, from 2002 to 2003 [J].
Almirante, B ;
Rodríguez, D ;
Park, BJ ;
Cuenca-Estrella, M ;
Planes, AM ;
Almela, M ;
Mensa, J ;
Sanchez, F ;
Ayats, J ;
Gimenez, M ;
Saballs, P ;
Fridkin, SK ;
Morgan, J ;
Rodriguez-Tudela, JL ;
Warnock, DW ;
Pahissa, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (04) :1829-1835
[2]   Increasing incidence of candidemia:: Results from a 20-year nationwide study in Iceland [J].
Asmundsdóttir, LR ;
Erlendsdóttir, H ;
Gottfredsson, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (09) :3489-3492
[3]   RETRACTED: Nationwide Sentinel Surveillance of Bloodstream Candida Infections in 40 Tertiary Care Hospitals in Spain (Retracted Article. See vol 49, pg 1193, 2011) [J].
Cisterna, R. ;
Ezpeleta, G. ;
Telleria, O. ;
Guinea, J. ;
Regueiro, B. ;
Garcia-Rodriguez, J. ;
Esperalba, J. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (11) :4200-4206
[4]   Frequency of Voriconazole Resistance In Vitro among Spanish Clinical Isolates of Candida spp. According to Breakpoints Established by the Antifungal Subcommittee of the European Committee on Antimicrobial Susceptibility Testing [J].
Cuenca-Estrella, M. ;
Gomez-Lopez, A. ;
Cuesta, I. ;
Zaragoza, O. ;
Mellado, E. ;
Rodriguez-Tudela, J. L. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (04) :1794-1797
[5]   Epidemiology of Candida species infections in critically ill non-immunosuppressed patients [J].
Eggimann, P ;
Garbino, J ;
Pittet, D .
LANCET INFECTIOUS DISEASES, 2003, 3 (11) :685-702
[6]   Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study [J].
Garey, Kevin W. ;
Rege, Milind ;
Pai, Manjunath P. ;
Mingo, Dana E. ;
Suda, Katie J. ;
Turpin, Robin S. ;
Bearden, David T. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (01) :25-31
[7]   Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry [J].
Horn, David L. ;
Neofytos, Dionissios ;
Anaissie, Elias J. ;
Fishman, Jay A. ;
Steinbach, William J. ;
Olyaei, Ali J. ;
Marr, Kieren A. ;
Pfaller, Michael A. ;
Chang, Chi-Hsing ;
Webster, Karen M. .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (12) :1695-1703
[8]   Candidemias: multicentre analysis in 16 hospitals in Andalusia (Spain) [J].
Jesus Rodriguez-Hernandez, M. ;
Ruiz-Perez de Pipaon, Maite ;
Marquez-Solero, Manuel ;
Martin-Rico, Patricia ;
Jose Caston-Osorio, Juan ;
Guerrero-Sanchez, Francisca M. ;
Vidal-Verdu, Elisa ;
Garcia-Figueras, Carolina ;
del Arco-Jimenez, Alfonso ;
Rodriguez-Bano, Jesus ;
Martin-Mazuelos, Estrella ;
Miguel Cisneros-Herreros, Jose .
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2011, 29 (05) :328-333
[9]   Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study [J].
Kett, Daniel H. ;
Azoulay, Elie ;
Echeverria, Pablo M. ;
Vincent, Jean-Louis .
CRITICAL CARE MEDICINE, 2011, 39 (04) :665-670
[10]   Risk factors for fluconazole resistance in patients with Candida glabrata bloodstream infection: Potential impact of control group selection on characterizing the association between previous fluconazole use and fluconazole resistance [J].
Lee, Ingi ;
Zaoutis, Theoklis E. ;
Fishman, Neil O. ;
Morales, Knashawn H. ;
Nachamkin, Irving ;
Lautenbach, Ebbing .
AMERICAN JOURNAL OF INFECTION CONTROL, 2010, 38 (06) :456-460